X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-02-02 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,106 | 47,659 | -4% | -$104,437 | |||||
2024-02-02 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,071 | 49,812 | -4% | -$102,701 | ||||||
| D | 2024-01-17 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $50.42 | -5,482 | 47,850 | -10% | -$276,386 | |||||
| D | 2024-01-12 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $53.50 | -8,000 | 38,170 | -17% | -$427,999 | |||||
| D | 2023-12-26 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $51.46 | -25,000 | 36,052 | -41% | -$1,286,575 | |||||
2023-02-06 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $40.67 | -1,413 | 24,946 | -5% | -$57,464 | ||||||
| D | 2023-01-18 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $39.57 | -4,752 | 22,326 | -18% | -$188,052 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |